Welltower is trading at $236.21, up +0.7% in pre-market, with no clear company-specific catalyst identified for the October 16 gain. - JPMorgan’s upgrade to Overweight with a $260 price target was reported in late September and does not establish a fresh catalyst. - Welltower’s next scheduled earnings release is October 26, 2026. - Supplied major-index moves were mixed and modest, offering no clear broad-market explanation.